Salaries and Expenses
Year | Budget Estimate to Congress |
House Allowance |
Senate Allowance |
Appropriation |
---|---|---|---|---|
1988 | 454,109,0001 | 450,504,000 | 454,109,000 | 450,504,000 |
1989 |
481,844,0002 | 481,844,000 | 481,844,000 | 481,844,0003 |
1990 | 556,571,0004 | 550,171,000 | 581,871,000 | 567,079,0005 |
1991 | 654,808,0006 | 654,808,000 | 661,652,000 | 656,519,0007 |
1992 | 737,604,0008 | 725,962,000 | 704,734,000 | 725,962,000 |
1993 | 757,038,0009 | 744,135,000 | 744,135,000 | 792,035,00010 |
1994 | 867,339,00011 | 867,339,000 | 692,339,000 | 870,123,00012 |
1995 |
926,007,00013 | 914,394,000 | 754,587,000 | 897,104,00014 |
1996 | 965,462,00015 | 917,694,000 | 917,694,000 | 917,694,00016 |
1997 |
964,178,00017 | 920,903,000 | 920,902,000 | 920,903,00018 |
1998 | 987,735,00019 | 866,467,000 | 978,227,000 | 962,671,00020 |
1999 | 1,153,259,00021 | 101,023,00022 | 124,025,00022 | 1,117,525,00023 |
2000 |
1,313,301,00024 | 1,214,231,000 | 1,196,819,000 | 1,199,677,00024 |
2001 | 1,354,989,00025 |
1 The FY 1988 request includes Amendments of +$8,880,000 for AIDS, -$2,357,000 for reduced FERS Agency contribution rate, and $33,800,000 proposed to be available from user fees.2 The FY 1989 request includes funding of $40,420,000 for AIDS-related work which was proposed to be funded in the AIDS Research and Education Account.3 The FY 1989 appropriation does not include $5,000,000 added in the Anti-Drug Abuse Act.4 The FY 1990 request includes $56,941,000 which was included in the proposed National HIV Program account, $13,900,000 requested as a supplemental appropriation, and $100,000,000 proposed to be available from user fees.5 The FY 1990 appropriation includes $7,092,000 which was subsequently sequestered.6 The FY 1991 request includes $157,175,000 proposed to be available from user fees.7 The FY 1991 appropriation includes $8,868 which was subsequently sequestered.8 The FY 1992 request includes $197,500,000 proposed to be available from user fees.9 The FY 1993 appropriation request includes $200,000,000 proposed to be available from user fees.10 The FY 1993 appropriation includes $1,900,000 to fund a clinical pharmacology pilot program; and a $3,000,000 supplemental for Mammography Quality Standards Act (MQSA) to be transferred from HCFA, NIH and CDC; and $36,000,000 for the Prescription Drug User Fee Act.11 The FY 1994 request includes $54,000,000 for the Prescription Drug User Fee Act (PDUFA); $64,600,000 for Investment Initiatives; $200,000,000 proposed to be available from User Fees.12 The FY 1994 appropriation includes $56,284,000 for PDUFA ($2,284 which was a supplemental appropriation), and $40,000,00 for Investment Initiatives.13 The FY 1995 1995 request includes $79,423,000 for PDUFA; $24,000,000 for Device User Fees; $6,500,000 for MQSA fee collections; and other user fees of $228,000,000. Also included is a transfer from Office of the Secretary, Office of General Counsel to FDA of $2,745,000 and 34 FTE.14 The FY 1995 appropriation includes an amended S&E BA of $817,681,000 and $79,423,000 for PDUFA. The amount does not include anticipated collections of MQSA inspections fees of $6,500,000. The level reflects the amended appropriation which rescinded $2,290,000.15 The FY 1996 request includes S&E BA of $828,999,000; $84,723,000 for PDUFA; $13,000,000 for MQSA fee collections; $23,740,00 for MDUFA; and $15,000,000 for Import fees.16 The FY 1996 appropriation includes S&E BA of $819,971,000; $84,723,000 for PDUFA; and $13,000,000 for MQSA fee collections.17 The FY 1997 request includes S&E BA of $823,771,000; $87,528,000 for PDUFA; $13,403,000 for MQSA fee collections; $24,476,00 for MDUFA; and 15,000,000 for Import fees.18 The FY 1997 appropriation includes S&E BA of $819,971,000; $87,528,000 for PDUFA; and $13,403,000 for MQSA fee collections.19 The FY 1998 request includes S&E BA of $750,922,000; $91,204,000 for PDUFA; $13,966,000 for MQSA; $131,643,000 for new user fees. Does not reflect proposed PDUFA Supplemental request of $25,618,000 requested with the FY 1999 President's Budget.20 The FY 1998 appropriation includes S&E BA of $857,501,000; $91,204,000 for PDUFA; and $13,966,000 for MQSA fee collections.21 The FY 1999 request includes S&E BA of $878,884,000; $132,273,000 for PDUFA; $14,385,000 for MQSA; and $127,717,000 for new user fees.22 The FY 1999 House Action, Senate Action and Appropriation included the GSA Rent within the S&E Appropriation (BA of $82,866,000; PDUFA of $5,428,000).23 The FY 1999 appropriation includes S&E BA of $888,001,000; GSA Rent of $82,866,000 $132,273,000 for PDUFA; and $14,385,000 for MQSA fee collections.24 The FY 2000 appropriation includes S&E BA of $1,109,950,000 (including $94,537,000 of GSA Rent, $3,000,000 for Seafood Transfer); $145,434,000 for PDUFA; $14,817,000 for MQSA; $12,700,000 for Seafood Transfer User Fees, $17,000,000 for new user fees, and $13,400,000 for Bioterrorism.25 The FY 2001 request includes S&E of $1,156,905,000 (including $99,094,000 of GSA Rent); $149,273,000 for PDUFA; $15,128,000 for MQSA; $12,700,000 for Seafood Transfer User Fees, $1,500,000 for Export Certification; and $19,483,000 for new user fees (Food Additive $8,400,000; Premarket Medical Devices $5,833,000; Foods Export Certification $5,250,000).
Year | Budget Estimate to Congress |
House Allowance |
Senate Allowance |
Appropriation |
---|---|---|---|---|
1988 | 34,495,000 | 25,612,000 | 34,495,000 | 25,612,000 |
1989 | 25,612,000 | 25,612,000 | 25,612,000 | 25,612,000 |
1990 | 25,612,000 | 25,612,000 | 25,612,000 | 25,612,000 |
1991 | 25,612,000 | 25,612,000 | 25,612,000 | 25,612,0001 |
1992 | 25,612,000 | 25,612,000 | 25,612,000 | 25,612,000 |
1993 | 25,612,000 | 25,612,000 | 25,612,000 | 25,612,000 |
1994 | 48,575,000 | 48,575,000 | 48,575,000 | 48,575,0002 |
1995 | 48,575,000 | 46,294,0003 | 46,294,000 | 46,294,0004 |
1996 | 46,294,000 | 46,294,000 | 46,294,000 | 46,294,0005 |
1997 | 46,294,000 | 46,294,000 | 46,294,000 | 46,294,0006 |
1998 | 46,294,0007 | 46,294,000 | 46,294,000 | 46,294,0007 |
1999 | 82,866,0008 | 82,866,0009 | 82,866,0009 | 88,866,0009 |
2000 | 100,180,00010 | 95,888,000 | 93,697,000 | 99,954,000 |
2001 | 99,094,00011 |
1 Does not reflect $333 which was subsequently sequestered.2 Includes $15,000,000 reserved for use by FDA for repairs and improvements to facilities.3 Reflects a GSA rent reduction of $2,281,000 to the rent cap.4 Includes an authorized reduction of GSA rent payments of $3,970,000 to cover FDA's Building Delegation expenses.5 Includes an authorized reduction of GSA rent payments of $3,957,000 to cover FDA's Building Delegation expenses.6 Includes an authorized reduction of GSA rent payments estimated to be $4,705,000 to cover FDA's Building Delegation expenses.7 Includes an authorized reduction of GSA rent payments estimated to be $4,832,000 to cover FDA's Building Delegation expenses.8 Includes an authorized reduction of GSA rent payments estimated to be $4,917,0000 to cover FDA's Building Delegation expenses and $5,428,000 of PDUFA collections.8 In FY 1999, Congress included GSA Rent in the S&E Appropriation. Includes an authorized reduction of GSA rent payments estimated to be $4,917,0000 to cover FDA's Building Delegation expenses and $5,428,000 of PDUFA collections.10 PDUFA collections of $5,643,000 are not included.11 PDUFA collections of $5,860,000 are not included.
Year | Budget Estimate to Congress |
House Allowance |
Senate Allowance |
Appropriation |
---|---|---|---|---|
1988 | 1,450,0001 | 1,450,000 | 1,450,000 | 1,450,000 |
1989 | 26,450,0001 | 23,710,000 | 25,736,000 | 23,950,000 |
1990 | 1,450,0001 | 6,950,000 | 12,250,000 | 8,350,000 |
1991 | 4,752,0001 | 8,350,000 | 10,850,000 | 8,350,000 |
1992 | 10,000,0001 | 10,400,000 | 8,350,000 | 8,350,0002 |
1993 | 8,350,000 | 8,350,000 | 8,350,000 | 8,350,000 |
1994 | 8,350,0003 | 8,350,000 | 8,350,000 | 8,350,000 |
1995 | 8,350,0004 | 18,150,000 | 8,350,000 | 18,150,0005 |
1996 | 8,350,000 | 15,150,000 | 8,350,000 | 12,150,0006 |
1997 | 8,350,000 | 21,350,000 | 21,350,000 | 21,350,0007 |
1998 | 22,900,0008 | 21,350,000 | 21,350,000 | 21,350,0008 |
1999 | 8,350,000 | 11,350,000 | 12,350,000 | 11,350,0009 |
2000 | 31,750,00010 | 31,750,000 | 8,350,000 | 11,350,000 |
2001 | 31,350,00011 |
1 Funding of facilities projects - 1984 through 1992 - was included in the Program Expenses request but appropriated in this account.2 Does not include $200,000,000 provided to GSA in the Treasury, Postal Service, General Government Appropriation Act of 1992 for consolidation of FDA headquarters facilities.3 Does not include $73,900,000 provided to GSA in the Treasury, Postal Service, General Government Appropriation Act of 1994 for consolidation of FDA headquarters facilities.4 Does not include $45,000,000 provided to GSA in the Treasury, Postal Service, General Government Appropriation Act of 1995 for consolidation of FDA headquarters facilities.5 Includes $9,800,000 to purchase land and begin engineering and design work for replacement of FDA's Los Angeles District office and laboratory.6 Includes $3,800,000 for continuing work on an Arkansas Regional Laboratory at Jefferson, AR.7 Includes $13,000,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.8 Includes $14,550,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.9 Includes $3,000,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.10 Includes $20,400,000 for construction of Phase I of the new Los Angeles Laboratory and $3,000,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.10 Includes $20,000,000 for construction of Phase I of the new Los Angeles Laboratory and $3,000,000 for continuing modernization of Arkansas Regional Laboratory at Jefferson, AR.
Edited 3/1/2000